When a woman requires gynecologic surgery, she and her surgeon have several minimally invasive surgical options, including robotic surgery. In recent years, the use of robotic surgery has become more and more common. But questions have arisen about the potential overuse of robotic surgery and its advantages over traditional laparotomy for hysterectomy.
A clinical opinion by Charles Rardin, MD, a urogynecologist in the Division of Urogynecology and Reconstructive Surgery and director of the Robotic Surgery Program for Women at Women & Infants Hospital of Rhode Island, director of Minimally Invasive Surgery at Care New England, and associate professor of obstetrics and gynecology at The Warren Alpert Medical School of Brown University, entitled "The debate over robotics in benign gynecology," is published this month in the American Journal of Obstetrics & Gynecology.
"Robotic surgery certainly provides some advantages to some surgeons and has contributed to a decline in laparotomy (large incision) rates for hysterectomy," said Dr. Rardin. "But robotic surgery for benign gynecology needs to be considered as just one of several forms of minimally invasive surgery (MIS) that can be used to provide the best care to patients."
Dr. Rardin explained that specific features of the patient (ie obesity), the surgeon (ie his or her experience with laparoscopic surgery), or the case (ie the possibility of significant and technically challenging suturing, such as required for a fistula repair) may make the robotic approach preferable over laparoscopic or vaginal surgery.
"However, an institution that adopts a policy of promoting robotic surgery over other forms of minimally invasive surgery is at risk of becoming a 'robotic factory' and allowing volume and quality of vaginal or laparoscopic surgeries to dwindle," he said.
In his opinion piece, Dr. Rardin suggests that other organizations consider the approach taken at the Care New England hospitals (Kent, Memorial and Women & Infants), which focuses on the ability to provide the full spectrum of MIS procedures to each individual patient presenting for surgical care. He outlines how hospitals and physicians could promote a balanced approach to MIS by considering four issues:
This year, Women & Infants Hospital was designated a Center of Excellence in Minimally Invasive Gynecology (COEMIG) by the Surgical Review Corporation, an affiliate of the American Association of Gynecologic Laparoscopists (AAGL), for its commitment to offering women the most effective diagnostic and therapeutic techniques in minimally invasive surgery.
Covering the full spectrum of the specialty, American Journal of Obstetrics & Gynecology, "The Gray Journal," presents the latest diagnostic procedures, leading-edge research, and expert commentary in maternal-fetal medicine, reproductive endocrinology and infertility, gynecologic oncology, and urogynecology, as well as general obstetrics and gynecology.
About Women & Infants Hospital
Women & Infants Hospital of Rhode Island, a Care New England hospital, is one of the nation's leading specialty hospitals for women and newborns. A major teaching affiliate of The Warren Alpert Medical School of Brown University for obstetrics, gynecology and newborn pediatrics, as well as a number of specialized programs in women's medicine, Women & Infants is the eighth largest stand-alone obstetrical service in the country with nearly 8,400 deliveries per year. In 2009, Women & Infants opened the country's largest, single-family room neonatal intensive care unit.
New England's premier hospital for women and newborns, Women & Infants and Brown offer fellowship programs in gynecologic oncology, maternal-fetal medicine, urogynecology and reconstructive pelvic surgery, neonatal-perinatal medicine, pediatric and perinatal pathology, gynecologic pathology and cytopathology, and reproductive endocrinology and infertility. It is home to the nation's only mother-baby perinatal psychiatric partial hospital, as well as the nation's only fellowship program in obstetric medicine.
Women & Infants has been designated as a Breast Center of Excellence from the American College of Radiography; a Center of Excellence in Minimally Invasive Gynecology; a Center for In Vitro Maturation Excellence by SAGE In Vitro Fertilization; a Center of Biomedical Research Excellence by the National Institutes of Health; and a Neonatal Resource Services Center of Excellence. It is one of the largest and most prestigious research facilities in high risk and normal obstetrics, gynecology and newborn pediatrics in the nation, and is a member of the National Cancer Institute's Gynecologic Oncology Group and the National Institutes of Health's Pelvic Floor Disorders Network.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.